AVRDB — Anteris Technologies Share Price
Last trade - 00:00- AU$214.14m
- AU$205.29m
- AU$7.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 42.47 | ||
| Price to Tang. Book | 52.31 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 33.79 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1036.27% | ||
| Return on Equity | -655.53% | ||
| Operating Margin | -1279.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 17.15 | 9.57 | 9.27 | 6.73 | 7.03 | 5.29 | 4.6 | -22.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Anteris Technologies Ltd is an Australia-based structural heart company. The Company is engaged in designing, developing, and commercializing medical devices. The Company’s lead product, DurAVR, is a transcatheter heart valve (THV) for treating aortic stenosis. DurAVR THV is made using ADAPT tissue, its patented anti-calcification tissue technology. DurAVR THV is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue. It is designed to mimic the performance of a pre-disease human aortic valve. Its balloon expandable ComASUR Delivery System provides controlled deployment and accurate placement of the DurAVR THV valve, designed to achieve precise alignment with the heart’s native commissures to achieve ideal valve positioning.
Directors
- John Seaberg NEC
- Wayne Paterson CEO (49)
- Matthew McDonnell CFO
- David Denis COO
- Helen Wray VOP
- Michael Oswell VPR
- Danny Zanardo DSL
- Lynne Bradshaw DMK
- Chris Meduri OTH
- Steve Denaro SEC
- Wenyi Gu DRC
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- June 23rd, 1999
- Public Since
- March 24th, 2004
- No. of Employees
- 1
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 19,222,316
- Address
- TOOWONG TOWER, TOOWONG, 4066
- Web
- https://anteristech.com/
- Phone
- +61 300550310
- Auditors
- KPMG
Latest News for AVRDB
Upcoming Events for AVRDB
Full Year 2024 Anteris Technologies Ltd Earnings Release
Anteris Technologies Ltd Annual Shareholders Meeting
Half Year 2025 Anteris Technologies Ltd Earnings Release
Similar to AVRDB
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
Atomo Diagnostics
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:16 UTC, shares in Anteris Technologies are trading at AU$12.55. This share price information is delayed by 15 minutes.
Shares in Anteris Technologies last closed at AU$12.55 and the price had moved by -25.39% over the past 365 days. In terms of relative price strength the Anteris Technologies share price has underperformed the ASX All Ordinaries Index by -31.53% over the past year.
The overall consensus recommendation for Anteris Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAnteris Technologies does not currently pay a dividend.
Anteris Technologies does not currently pay a dividend.
Anteris Technologies does not currently pay a dividend.
To buy shares in Anteris Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$12.55, shares in Anteris Technologies had a market capitalisation of AU$241.24m.
Here are the trading details for Anteris Technologies:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AVR
Based on an overall assessment of its quality, value and momentum Anteris Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Anteris Technologies is AU$20.50. That is 63.35% above the last closing price of AU$12.55.
Analysts covering Anteris Technologies currently have a consensus Earnings Per Share (EPS) forecast of -AU$4.35 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Anteris Technologies. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -20.2%.
As of the last closing price of AU$12.55, shares in Anteris Technologies were trading -8.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Anteris Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$12.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Anteris Technologies' management team is headed by:
- John Seaberg - NEC
- Wayne Paterson - CEO
- Matthew McDonnell - CFO
- David Denis - COO
- Helen Wray - VOP
- Michael Oswell - VPR
- Danny Zanardo - DSL
- Lynne Bradshaw - DMK
- Chris Meduri - OTH
- Steve Denaro - SEC
- Wenyi Gu - DRC